EVAX
Price
$4.87
Change
-$0.39 (-7.41%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
43.67M
Intraday BUY SELL Signals
WXIBF
Price
$4.50
Change
-$0.00 (-0.00%)
Updated
Nov 6 closing price
Capitalization
16.84B
Intraday BUY SELL Signals
Interact to see
Advertisement

EVAX vs WXIBF

Header iconEVAX vs WXIBF Comparison
Open Charts EVAX vs WXIBFBanner chart's image
Evaxion A/S
Price$4.87
Change-$0.39 (-7.41%)
Volume$300
Capitalization43.67M
Wuxi Biologics (Cayman)
Price$4.50
Change-$0.00 (-0.00%)
Volume$1.15K
Capitalization16.84B
EVAX vs WXIBF Comparison Chart in %
EVAX
Daily Signal:
Gain/Loss:
WXIBF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EVAX vs. WXIBF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVAX is a Hold and WXIBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (EVAX: $5.26 vs. WXIBF: $4.50)
Brand notoriety: EVAX and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVAX: 2% vs. WXIBF: 69%
Market capitalization -- EVAX: $40.52M vs. WXIBF: $16.86B
EVAX [@Biotechnology] is valued at $40.52M. WXIBF’s [@Biotechnology] market capitalization is $16.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVAX’s FA Score shows that 0 FA rating(s) are green whileWXIBF’s FA Score has 1 green FA rating(s).

  • EVAX’s FA Score: 0 green, 5 red.
  • WXIBF’s FA Score: 1 green, 4 red.
According to our system of comparison, WXIBF is a better buy in the long-term than EVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVAX’s TA Score shows that 2 TA indicator(s) are bullish while WXIBF’s TA Score has 5 bullish TA indicator(s).

  • EVAX’s TA Score: 2 bullish, 7 bearish.
  • WXIBF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, WXIBF is a better buy in the short-term than EVAX.

Price Growth

EVAX (@Biotechnology) experienced а -12.33% price change this week, while WXIBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($16.8B) has a higher market cap than EVAX($43.7M). WXIBF YTD gains are higher at: 107.373 vs. EVAX (24.438). WXIBF has higher annual earnings (EBITDA): 5.5B vs. EVAX (-11.76M). WXIBF has higher revenues than EVAX: WXIBF (17B) vs EVAX (3.18M).
EVAXWXIBFEVAX / WXIBF
Capitalization43.7M16.8B0%
EBITDA-11.76M5.5B-0%
Gain YTD24.438107.37323%
P/E RatioN/A32.60-
Revenue3.18M17B0%
Total Cash14.7MN/A-
Total Debt11.3MN/A-
FUNDAMENTALS RATINGS
WXIBF: Fundamental Ratings
WXIBF
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
13

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVAXWXIBF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EVAX
Daily Signal:
Gain/Loss:
WXIBF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MXCHY1.930.18
+10.29%
Orbia Advance Corp S A B
PCB21.160.01
+0.05%
PCB Bancorp
WHREY13.33N/A
N/A
Wharf Real Estate Investment Co Ltd.
MCRP1.23-0.09
-6.82%
Micropolis Holding Company
KSTOF2.12-0.22
-9.57%
KISTOS HOLDINGS PLC

EVAX and

Correlation & Price change

A.I.dvisor tells us that EVAX and KURA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVAX and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVAX
1D Price
Change %
EVAX100%
+0.96%
KURA - EVAX
31%
Poorly correlated
+2.12%
KYTX - EVAX
30%
Poorly correlated
+9.50%
HYPD - EVAX
28%
Poorly correlated
+17.65%
SPRB - EVAX
27%
Poorly correlated
+6.08%
REPL - EVAX
26%
Poorly correlated
-0.34%
More

WXIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXIBF has been loosely correlated with WXXWY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXIBF jumps, then WXXWY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
N/A
WXXWY - WXIBF
46%
Loosely correlated
+0.49%
JAGX - WXIBF
22%
Poorly correlated
-9.14%
NVAX - WXIBF
21%
Poorly correlated
-3.38%
ELVAF - WXIBF
21%
Poorly correlated
N/A
EVAX - WXIBF
20%
Poorly correlated
+0.96%
More